BRKR · Bruker Corp
$60.45
-1.70 (-2.74%)
At close · Jul 24
Market Cap
$9.37B
Shares
154.99M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.44B
+2.1%
FY2025
Net Income
-$8.6M
-107.6%
FY2025
Gross Margin
45.91%
-3.1pp
FY2025
Operating Margin
1.98%
-5.5pp
FY2025
Diluted EPS
-$0.15
-119.7%
FY2025
Operating Cash Flow
$134.1M
-46.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.57B – $3.6B | $3.46B | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B | $1.99B | $2.07B | $1.9B | $1.77B | $1.61B | $1.62B | $1.81B | $1.84B | $1.79B | $1.65B | $1.3B | $1.11B | |
| — | $1.89B | $1.86B | $1.72B | $1.45B | $1.23B | $1.21B | $1.05B | $1.08B | $995.6M | $949.9M | $866M | $915.2M | $1.05B | $1.03B | $962M | $899.2M | $700.9M | $597M | |
| — | $1.57B | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B | $939.8M | $995.3M | $900M | $816M | $745.3M | $708.6M | $763.3M | $805.2M | $829.4M | $752.5M | $604M | $517.5M | |
| — | — | 45.91% | 49% | 51.05% | 51.59% | 50.03% | 47.29% | 48.02% | 47.48% | 46.21% | 46.25% | 43.64% | 42.2% | 43.78% | 46.3% | 45.56% | 46.29% | 46.43% | |
| — | $399.4M | $395.2M | $376.5M | $294.8M | $235.9M | $220.8M | $198M | $187.7M | $173.4M | $161.6M | $147.9M | $145.7M | $174.2M | $190.5M | $195.3M | $177.2M | $141.4M | $126.4M | |
| — | $963.2M | $946.5M | $893.8M | $729.4M | $607.4M | $561.2M | $468.6M | $500.2M | $444.7M | $415.2M | $389.8M | $392.2M | $451M | $437.9M | $440.4M | $406.6M | $301.1M | $254M | |
| — | $126.4M | $121.2M | $99.1M | $47.1M | $37.1M | $37.4M | $35.8M | $38.3M | $28.9M | $29.6M | $21.7M | $20.7M | $20.2M | $20.8M | $22M | $18.1M | — | — | |
| — | $228.2M | $220.3M | $183.8M | $114.9M | $88.8M | $89.1M | $80.4M | $75.6M | $64.9M | $63.9M | $54.3M | $53.3M | $59.7M | $61.3M | $59.1M | $52.9M | $36.1M | $29.7M | |
| — | $85M | $77.4M | $24.7M | $22.3M | $4.8M | $8.2M | $15.8M | $1.4M | $9.4M | $16.2M | $20.8M | $29.3M | $36.1M | $25.3M | $500K | $1M | $200K | $200K | |
| — | $1.52B | $1.51B | $1.4B | $1.08B | $873M | $796.3M | $691.5M | $694.4M | $637.6M | $596.5M | $563.5M | $562.9M | $657.9M | $657M | $673.4M | $596.9M | $448.3M | $380.8M | |
| — | $46.6M | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M | $248.3M | $300.9M | $262.4M | $219.5M | $181.8M | $145.7M | $105.4M | $148.2M | $156M | $155.6M | $155.7M | $136.7M | |
| — | — | 1.98% | 7.52% | 14.74% | 17.1% | 17.09% | 12.49% | 14.52% | 13.84% | 12.43% | 11.28% | 8.97% | 5.83% | 8.06% | 8.71% | 9.42% | 11.93% | 12.27% | |
| — | $274.8M | $288.5M | $436.9M | $551.8M | $521.5M | $502.4M | $328.7M | $376.5M | $327.3M | $283.4M | $236.1M | $199M | $165.1M | $209.5M | $215.1M | $208.5M | $191.8M | $166.4M | |
| — | $59.4M | $60.3M | $47.9M | $16.4M | $16.1M | $14.3M | $14.4M | $16M | $12.6M | $15.4M | $13.2M | $13M | $13.3M | $13.4M | $14.3M | $7.3M | $5.6M | $7.5M | |
| — | $16.6M | $14.8M | $9.3M | $7.5M | $2.8M | $900K | $3.2M | $1.3M | $1.2M | $800K | $300K | $1.2M | $800K | $1M | $900K | $1M | $900K | $1M | |
| — | -$27.8M | -$46.2M | -$46.2M | $107.3M | -$18.8M | -$19.7M | -$22.5M | -$20.5M | -$17.7M | -$21.7M | -$4.2M | -$17.7M | -$4.1M | -$23.6M | -$17.7M | -$10.1M | -$5.6M | $800K | |
| — | $18.8M | $22M | $206.9M | $544.2M | $413.9M | $393.6M | $225.8M | $280.4M | $244.7M | $197.8M | $177.6M | $128M | $101.3M | $124.6M | $138.3M | $145.5M | $150.1M | $129.1M | |
| — | $23.1M | $29.3M | $91.4M | $117.7M | $116.4M | $113M | $64.4M | $82.4M | $63.7M | $117.5M | $23.1M | $23.1M | $41.7M | $42.8M | $60.1M | $51.5M | $53.3M | $48.1M | |
| — | -$11.6M | -$8.6M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M | $78.6M | $153.6M | $101.6M | $56.7M | $80.1M | $77.5M | $92.3M | $95.4M | $81M | |
| — | — | -0.25% | 3.36% | 14.41% | 11.72% | 11.46% | 7.94% | 9.51% | 9.48% | 4.45% | 9.53% | 6.26% | 3.13% | 4.35% | 4.33% | 5.59% | 7.31% | 7.27% | |
| — | $2.2M | $300K | $700K | $1.3M | $1.9M | $3.5M | $3.6M | $800K | $1.3M | $1.7M | $900K | $3.3M | $2.9M | $1.7M | $700K | $1.7M | $1.4M | -$200K | |
| — | — | -$22.5M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M | $78.6M | $153.6M | $101.6M | $56.7M | $80.1M | $77.5M | $92.3M | $95.4M | $81.2M | |
| — | -$28.8M | $15.4M | $3.6M | $418.4M | $319.6M | $267.8M | $187M | $154.7M | $169.7M | $181.5M | $121.9M | $29.2M | -$97.5M | $124.8M | $72.8M | $82.4M | $94.3M | — | |
| USD/shares | — | — | -$0.15 | $0.76 | $2.92 | $2.00 | $1.83 | $1.03 | $1.27 | $1.15 | $0.50 | $0.95 | $0.60 | $0.34 | $0.48 | $0.47 | $0.56 | $0.58 | $0.50 |
| USD/shares | $2.10 – $2.15* | — | -$0.15 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 | $0.60 | $0.33 | $0.48 | $0.46 | $0.55 | $0.58 | $0.49 |
| shares | — | — | 151.8M | 149M | 146.4M | 148.6 | 151.4 | 153.4 | 155.2 | 156.2M | 158.1M | 161.4M | 168.2M | 167.8M | 166.5M | 166M | 165.4M | 164.4M | 163.5M |
| shares | — | — | 151.8M | 149.5M | 147.2M | 149.4 | 152.9 | 154.6 | 156.6 | 157.2M | 159.1M | 162.2M | 169.1M | 169.5M | 168.5M | 167.4M | 166.9M | 165.7M | 164.9M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $1.25B in buybacks, $262.3M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.03×
P/E (TTM)
—
Medical Devices median 27.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Bsi Calid | $1,210,200,000 | $1,093,500,000 | $960,400,000 | $822,200,000 | $819,600,000 | $653,900,000 | — | — |
| BSI Nano | $1,084,300,000 | $1,098,300,000 | $941,900,000 | $787,000,000 | $697,500,000 | $556,100,000 | $632,700,000 | $568,100,000 |
| Bsi Biospin | $878,800,000 | $905,700,000 | $798,500,000 | $696,700,000 | $691,000,000 | $600,000,000 | — | — |
| Energy and Supercon Technologies | $263,200,000 | $268,900,000 | $263,700,000 | $224,800,000 | $223,800,000 | $189,500,000 | $209,900,000 | $194,800,000 |
| Bruker BioSpin Group | — | — | — | — | $691,000,000 | $600,000,000 | $621,400,000 | $591,100,000 |
| Bruker Calid Group | — | — | — | — | $819,600,000 | $653,900,000 | $623,500,000 | $547,800,000 |
| Bruker Nano Group | — | — | — | — | $697,500,000 | $556,100,000 | $632,700,000 | $568,100,000 |
| Scientific Instruments Material Science | — | — | — | — | — | — | $632,700,000 | $568,100,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Europe Excluding Germany | $950,200,000 | $873,000,000 | $699,700,000 | — | — | — | — | — |
| United States | $891,300,000 | $938,500,000 | $777,700,000 | $696,100,000 | $601,000,000 | $455,900,000 | $529,800,000 | $489,400,000 |
| Asia Pacific Excluding China | $552,600,000 | $518,500,000 | $460,900,000 | — | — | — | — | — |
| China | $475,800,000 | $471,200,000 | $528,100,000 | $396,500,000 | $357,600,000 | $313,500,000 | — | — |
| Germany | $297,000,000 | $310,700,000 | $281,500,000 | $247,400,000 | $262,600,000 | $244,900,000 | $213,600,000 | $201,100,000 |
| Other Country | $269,600,000 | $254,500,000 | $216,600,000 | $190,400,000 | $167,100,000 | $137,800,000 | $173,000,000 | $155,700,000 |
| Rest of Asia Pacific | — | — | — | $408,400,000 | — | — | — | — |
| Rest of Europe | — | — | — | $591,900,000 | $658,100,000 | $519,800,000 | $505,200,000 | $500,200,000 |
| Asia Pacific | — | — | — | — | $371,500,000 | $315,600,000 | $651,000,000 | $549,200,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product | $2,766,400,000 | $2,759,200,000 | $2,457,600,000 | $2,109,900,000 | $2,017,300,000 | $1,638,100,000 | $1,744,700,000 | $1,576,600,000 |
| Product And Service Other | $670,100,000 | $607,200,000 | $506,900,000 | $420,800,000 | $7,400,000 | $6,000,000 | $5,500,000 | $7,300,000 |
| Service | — | — | — | — | $393,200,000 | $343,400,000 | $322,400,000 | $311,700,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Unallocated Expenses | $364,800,000 | $264,900,000 | $109,400,000 | $72,900,000 | — | — | — | — |
| Bsi Calid | $262,600,000 | $246,200,000 | $232,100,000 | $216,400,000 | $227,200,000 | $152,200,000 | — | — |
| Bsi Biospin | $156,500,000 | $216,600,000 | $211,200,000 | $187,700,000 | $158,200,000 | $121,600,000 | — | — |
| BSI Nano | $101,100,000 | $123,900,000 | $158,400,000 | $138,100,000 | $73,400,000 | $23,600,000 | $40,400,000 | $48,400,000 |
| Energy and Supercon Technologies | $26,700,000 | $35,100,000 | $32,500,000 | $30,400,000 | $22,200,000 | $6,200,000 | $16,400,000 | $14,500,000 |
| Scientific Instruments Material Science | — | — | — | — | — | — | $40,400,000 | $48,400,000 |
| Scientific Instruments | — | — | — | — | $385,400,000 | $273,800,000 | $290,300,000 | $244,000,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Bsi Calid | 21.7% | 22.5% | 24.2% | 26.3% | 27.7% | 23.3% | — | — |
| BSI Nano | 9.3% | 11.3% | 16.8% | 17.5% | 10.5% | 4.2% | 6.4% | 8.5% |
| Bsi Biospin | 17.8% | 23.9% | 26.4% | 26.9% | 22.9% | 20.3% | — | — |
| Energy and Supercon Technologies | 10.1% | 13.1% | 12.3% | 13.5% | 9.9% | 3.3% | 7.8% | 7.4% |
| Scientific Instruments Material Science | — | — | — | — | — | — | 6.4% | 8.5% |
Key facts
CIK
1109354
CUSIP
116794108
13F (30d)
74 filings
74 filers
Visit website
Investor relations